Citation: Sc. Ning et al., RADIOBIOLOGICAL STUDIES OF RADIOIMMUNOTHERAPY AND EXTERNAL-BEAM RADIOTHERAPY IN-VITRO AND IN-VIVO IN HUMAN RENAL-CELL CARCINOMA XENOGRAFTS, Cancer, 80(12), 1997, pp. 2519-2528
Authors:
DEB N
GORIS M
TRISLER K
FOWLER S
SAAL J
NING SC
BECKER M
MARQUEZ C
KNOX S
Citation: N. Deb et al., TREATMENT OF HORMONE-REFRACTORY PROSTATE-CANCER WITH Y-90 CYT-356 MONOCLONAL-ANTIBODY, Clinical cancer research, 2(8), 1996, pp. 1289-1297
Authors:
KNOX SJ
GORIS ML
TRISLER K
NEGRIN R
DAVIS T
LILES TM
GRILLOLOPEZ A
CHINN P
VARNS C
NING SC
FOWLER S
DEB N
BECKER M
MARQUEZ C
LEVY R
Citation: Sj. Knox et al., YTTRIUM-90-LABELED ANTI-CD20 MONOCLONAL-ANTIBODY THERAPY OF RECURRENTB-CELL LYMPHOMA, Clinical cancer research, 2(3), 1996, pp. 457-470
Authors:
NING S
TRISLER K
BROWN DM
YU NY
KANEKAL S
LUNDSTEN MJ
KNOX SJ
Citation: S. Ning et al., INTRATUMORAL RADIOIMMUNOTHERAPY OF A HUMAN COLON-CANCER XENOGRAFT USING A SUSTAINED-RELEASE GEL, Radiotherapy and oncology, 39(2), 1996, pp. 179-189
Citation: K. Trisler et S. Knox, ASSOCIATION OF BCL-2 OVER-EXPRESSION WITH ALTERED PROLIFERATION, CELL-CYCLE DISTRIBUTION AND PKC TRANSLOCATION FOLLOWING PHORBOL-MYRISTATE ACETATE (PMA) ACTIVATION, The FASEB journal, 9(3), 1995, pp. 123-123
Citation: K. Trisler et S. Specter, DELTA-9-TETRAHYDROCANNABINOL TREATMENT RESULTS IN A SUPPRESSION OF INTERLEUKIN-2-INDUCED CELLULAR ACTIVITIES IN HUMAN AND MURINE LYMPHOCYTES, International journal of immunopharmacology, 16(7), 1994, pp. 593